Publication

Involvement of residues 296-299 in the enzymatic activity of tissue-type plasminogen activator

Related publications (14)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Involvement of residues 296-299 in the enzymatic activity of tissue-type plasminogen activator

Graph Chatbot

Chat with Graph Search

Highly Efficient Cardiac Differentiation and Maintenance by Thrombin-Coagulated Fibrin Hydrogels Enriched with Decellularized Porcine Heart Extracellular Matrix

Development of cyclic peptide inhibitors of coagulation factor XIa for safer anticoagulation

Development of cyclic peptide inhibitors of coagulation factor XII and matrix metalloproteinase 2

Microdevice for Sedimentation-based Separation of Blood Microsamples at the Point of Collection

Improving the binding affinity of in-vitro-evolved cyclic peptides by inserting atoms into the macrocycle backbone

Rat bladder muscle regeneration induced by local delivery of an engineered insulin-like growth factor 1 in fibrin gels

Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension

Development of fibrin derivatives for controlled release of heparin-binding growth factors

A new photopolymerizable blood vessel glue that seals human vessel anastomoses without augmenting thrombogenicity

A slow clearing, fibrin-specific, PAI-1 resistant variant of t-PA (T103N, KHRR 296-299 AAAA)